MRP Capital Investments’s Sanofi SNY Stock Holding History

MRP Capital Investments’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$545	–	245
2023 Q1	$545	Buy	+10	New	+$486	﹤0.01%	223

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

MRP Capital Investments's SNY Position: Q2 2023 in Review

MRP Capital Investments sold out of Sanofi (SNY) in Q2 2023, closing a stake of 10 shares — an estimated $545 sold.

MRP Capital Investments first reported a position in SNY in Q1 2023 and held it in 1 quarter. The position peaked at $545 in Q1 2023. 673 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

MRP Capital Investments reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
MRP Capital Investments sold 10 Sanofi shares in Q2 2023, an estimated $545.
MRP Capital Investments first reported a position in Sanofi in Q1 2023 and held it in 1 quarter.
MRP Capital Investments's Sanofi position peaked at $545 in Q1 2023.
673 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on MRP Capital Investments's 13F filing for Q2 2023, filed 24 Jul 2023.